Internal Medicine · Salem, UT
NPI
1255435244
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
555 West Sr 164 North
Salem, UT, 84651
Phone (801) 465-4813
Groups this clinician bills Medicare through
Medicare paid, 2024
$71K
2,292 services
Medicare patients, 2024
144
Average age 75
Drug cost, 2024
$2.0M
11,706 prescriptions
Company payments, 2025
$1,362
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David F Bennion was code 99214 (office e&m - established), 458 times for 138 patients. In total David F Bennion billed 2,292 services in 77 codes, and Medicare paid $71K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 458 | 138 | $79.00 | $36K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 265 | 119 | $11.15 | $2,955 |
| 36415 Venipuncture Blood Collection | Office | 233 | 103 | $8.41 | $1,959 |
| 83036 Blood Count | Office | 118 | 49 | $9.52 | $1,123 |
| 85027 Blood Count | Office | 95 | 71 | $6.34 | $602 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 93 | 93 | $123.00 | $11K |
| 80069 Clinical Chemistry | Office | 86 | 40 | $8.35 | $718 |
| 80053 Clinical Chemistry | Office | 84 | 71 | $10.25 | $861 |
| 17003 Destruction Skin Lesion | Office | 81 | 11 | $4.15 | $336 |
| 80061 Clinical Chemistry | Office | 74 | 67 | $13.12 | $971 |
| 82043 Clinical Chemistry | Office | 50 | 41 | $5.66 | $283 |
| 82570 Clinical Chemistry | Office | 50 | 41 | $5.08 | $254 |
| 84443 Clinical Chemistry | Office | 43 | 35 | $16.46 | $708 |
| 81001 Clinical Chemistry | Office | 37 | 22 | $3.04 | $112 |
| 85652 Clinical Chemistry | Office | 33 | 25 | $2.52 | $83.05 |
By year: 2022 $61K for 1,709 services; 2023 $68K for 1,856 services; 2024 $71K for 2,292 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 233 | 103 | $8.41 | $1,959 |
| 83036 Blood Count | 118 | 49 | $9.52 | $1,123 |
| 85027 Blood Count | 95 | 71 | $6.34 | $602 |
| 80069 Clinical Chemistry | 86 | 40 | $8.35 | $718 |
| 80053 Clinical Chemistry | 84 | 71 | $10.25 | $861 |
| 80061 Clinical Chemistry | 74 | 67 | $13.12 | $971 |
| 82570 Clinical Chemistry | 50 | 41 | $5.08 | $254 |
| 82043 Clinical Chemistry | 50 | 41 | $5.66 | $283 |
| 84443 Clinical Chemistry | 43 | 35 | $16.46 | $708 |
| 81001 Clinical Chemistry | 37 | 22 | $3.04 | $112 |
Medicare prescription drug claims, 2024
In 2024, the drug David F Bennion prescribed most often to Medicare patients was Atorvastatin Calcium, with 356 prescriptions and refills. In total David F Bennion wrote 11,706 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 356 | 1,021 | 108 | $3,452 |
| Levothyroxine Sodium Generic | 355 | 914 | 84 | $4,240 |
| Pantoprazole Sodium Generic | 273 | 642 | 75 | $3,751 |
| Alprazolam Generic | 253 | 278 | 42 | $3,089 |
| Gabapentin Generic | 252 | 477 | 63 | $8,937 |
| Omeprazole Generic | 244 | 623 | 72 | $6,764 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 220 | 220 | 28 | $9,001 |
| Zolpidem Tartrate Generic | 201 | 260 | 33 | $1,902 |
| Trazodone Hcl Generic | 201 | 368 | 49 | $2,530 |
| Rosuvastatin Calcium Generic | 189 | 537 | 50 | $2,890 |
| Amlodipine Besylate Generic | 180 | 443 | 55 | $1,481 |
| Losartan Potassium Generic | 169 | 475 | 53 | $1,969 |
| Ozempic Semaglutide | 166 | 226 | 28 | $206K |
| Metformin Hcl Er Metformin Hcl | 160 | 405 | 41 | $2,539 |
| Montelukast Sodium Generic | 158 | 436 | 53 | $1,847 |
Brand drugs: 1,599 claims; generic drugs: 10,075 claims; opioid claims: 856.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David F Bennion $1,362 ($1,362 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $358.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 32 | $358 |
| Pfizer Inc. PFE | 23 | $218 |
| Axsome Therapeutics, Inc. AXSM | 10 | $169 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $144 |
| Astellas Pharma US Inc 4503.T | 7 | $143 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $86.42 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $49.03 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $39.52 |
| Amgen Inc. AMGN | 2 | $28.93 |
| Edwards Lifesciences Corporation EW | 1 | $24.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.